 | • レポートコード：D0GIR-02959 • 出版社/出版日：GlobalInfoResearch / 2020年9月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、細胞生存率アッセイの世界市場を広く調査・分析し、今後の市場展望をまとめております。細胞生存率アッセイの種類別市場規模（ヒト細胞、微生物細胞、動物細胞）、用途別市場規模（製薬・バイオテクノロジー企業、学術・研究機関、病院・診断研究所、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Thermo Fisher Scientific、Promega、GE、Merck、PerkinElmer、Bio-Rad、Abcam、BD、Danaher、Biotium、Creative Bioarray、Biotek Instruments ・地域別グローバル市場分析 2015年-2020年 ・細胞生存率アッセイの北米市場（アメリカ、カナダ、メキシコ） ・細胞生存率アッセイのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・細胞生存率アッセイのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・細胞生存率アッセイの南米市場（ブラジル、アルゼンチン） ・細胞生存率アッセイの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：ヒト細胞、微生物細胞、動物細胞 ・用途別分析：製薬・バイオテクノロジー企業、学術・研究機関、病院・診断研究所、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Cell Viability Assays market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.6% in the forecast period of 2020 to 2025 and will expected to reach USD 3022.5 million by 2025, from USD 2528.9 million in 2019.
The Cell Viability Assays market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Cell Viability Assays market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Cell Viability Assays market has been segmented into:
Human Cells
Microbial Cells
Animal Cells
By Application, Cell Viability Assays has been segmented into:
Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Hospital and Diagnostic Laboratories
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Cell Viability Assays market presented in the report. This section sheds light on the sales growth of different regional and country-level Cell Viability Assays markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Cell Viability Assays market.
The report offers in-depth assessment of the growth and other aspects of the Cell Viability Assays market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Cell Viability Assays Market Share Analysis
Cell Viability Assays competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Cell Viability Assays sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Cell Viability Assays sales, revenue and market share for each player covered in this report.
The major players covered in Cell Viability Assays are:
Thermo Fisher Scientific
Promega
GE
Merck
PerkinElmer
Bio-Rad
Abcam
BD
Danaher
Biotium
Creative Bioarray
Biotek Instruments
Table of Contents
1 Cell Viability Assays Market Overview
1.1 Product Overview and Scope of Cell Viability Assays
1.2 Classification of Cell Viability Assays by Type
1.2.1 Global Cell Viability Assays Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Cell Viability Assays Revenue Market Share by Type in 2019
1.2.3 Human Cells
1.2.4 Microbial Cells
1.2.5 Animal Cells
1.3 Global Cell Viability Assays Market by Application
1.3.1 Overview: Global Cell Viability Assays Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Pharmaceutical and Biotechnology Companies
1.3.3 Academic and Research Institutes
1.3.4 Hospital and Diagnostic Laboratories
1.3.5 Others
1.4 Global Cell Viability Assays Market by Regions
1.4.1 Global Cell Viability Assays Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Cell Viability Assays (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Cell Viability Assays Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Cell Viability Assays Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Cell Viability Assays Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Cell Viability Assays Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Cell Viability Assays Status and Prospect (2015-2025)
2 Company Profiles
2.1 Thermo Fisher Scientific
2.1.1 Thermo Fisher Scientific Details
2.1.2 Thermo Fisher Scientific Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Thermo Fisher Scientific SWOT Analysis
2.1.4 Thermo Fisher Scientific Product and Services
2.1.5 Thermo Fisher Scientific Cell Viability Assays Revenue, Gross Margin and Market Share (2018-2019)
2.2 Promega
2.2.1 Promega Details
2.2.2 Promega Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Promega SWOT Analysis
2.2.4 Promega Product and Services
2.2.5 Promega Cell Viability Assays Revenue, Gross Margin and Market Share (2018-2019)
2.3 GE
2.3.1 GE Details
2.3.2 GE Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 GE SWOT Analysis
2.3.4 GE Product and Services
2.3.5 GE Cell Viability Assays Revenue, Gross Margin and Market Share (2018-2019)
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Merck SWOT Analysis
2.4.4 Merck Product and Services
2.4.5 Merck Cell Viability Assays Revenue, Gross Margin and Market Share (2018-2019)
2.5 PerkinElmer
2.5.1 PerkinElmer Details
2.5.2 PerkinElmer Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 PerkinElmer SWOT Analysis
2.5.4 PerkinElmer Product and Services
2.5.5 PerkinElmer Cell Viability Assays Revenue, Gross Margin and Market Share (2018-2019)
2.6 Bio-Rad
2.6.1 Bio-Rad Details
2.6.2 Bio-Rad Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Bio-Rad SWOT Analysis
2.6.4 Bio-Rad Product and Services
2.6.5 Bio-Rad Cell Viability Assays Revenue, Gross Margin and Market Share (2018-2019)
2.7 Abcam
2.7.1 Abcam Details
2.7.2 Abcam Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Abcam SWOT Analysis
2.7.4 Abcam Product and Services
2.7.5 Abcam Cell Viability Assays Revenue, Gross Margin and Market Share (2018-2019)
2.8 BD
2.8.1 BD Details
2.8.2 BD Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 BD SWOT Analysis
2.8.4 BD Product and Services
2.8.5 BD Cell Viability Assays Revenue, Gross Margin and Market Share (2018-2019)
2.9 Danaher
2.9.1 Danaher Details
2.9.2 Danaher Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Danaher SWOT Analysis
2.9.4 Danaher Product and Services
2.9.5 Danaher Cell Viability Assays Revenue, Gross Margin and Market Share (2018-2019)
2.10 Biotium
2.10.1 Biotium Details
2.10.2 Biotium Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Biotium SWOT Analysis
2.10.4 Biotium Product and Services
2.10.5 Biotium Cell Viability Assays Revenue, Gross Margin and Market Share (2018-2019)
2.11 Creative Bioarray
2.11.1 Creative Bioarray Details
2.11.2 Creative Bioarray Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Creative Bioarray SWOT Analysis
2.11.4 Creative Bioarray Product and Services
2.11.5 Creative Bioarray Cell Viability Assays Revenue, Gross Margin and Market Share (2018-2019)
2.12 Biotek Instruments
2.12.1 Biotek Instruments Details
2.12.2 Biotek Instruments Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Biotek Instruments SWOT Analysis
2.12.4 Biotek Instruments Product and Services
2.12.5 Biotek Instruments Cell Viability Assays Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Cell Viability Assays Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Cell Viability Assays Players Market Share
3.2.2 Top 10 Cell Viability Assays Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Cell Viability Assays Revenue and Market Share by Regions
4.2 North America Cell Viability Assays Revenue and Growth Rate (2015-2020)
4.3 Europe Cell Viability Assays Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Cell Viability Assays Revenue and Growth Rate (2015-2020)
4.5 South America Cell Viability Assays Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Cell Viability Assays Revenue and Growth Rate (2015-2020)
5 North America Cell Viability Assays Revenue by Countries
5.1 North America Cell Viability Assays Revenue by Countries (2015-2020)
5.2 USA Cell Viability Assays Revenue and Growth Rate (2015-2020)
5.3 Canada Cell Viability Assays Revenue and Growth Rate (2015-2020)
5.4 Mexico Cell Viability Assays Revenue and Growth Rate (2015-2020)
6 Europe Cell Viability Assays Revenue by Countries
6.1 Europe Cell Viability Assays Revenue by Countries (2015-2020)
6.2 Germany Cell Viability Assays Revenue and Growth Rate (2015-2020)
6.3 UK Cell Viability Assays Revenue and Growth Rate (2015-2020)
6.4 France Cell Viability Assays Revenue and Growth Rate (2015-2020)
6.5 Russia Cell Viability Assays Revenue and Growth Rate (2015-2020)
6.6 Italy Cell Viability Assays Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Cell Viability Assays Revenue by Countries
7.1 Asia-Pacific Cell Viability Assays Revenue by Countries (2015-2020)
7.2 China Cell Viability Assays Revenue and Growth Rate (2015-2020)
7.3 Japan Cell Viability Assays Revenue and Growth Rate (2015-2020)
7.4 Korea Cell Viability Assays Revenue and Growth Rate (2015-2020)
7.5 India Cell Viability Assays Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Cell Viability Assays Revenue and Growth Rate (2015-2020)
8 South America Cell Viability Assays Revenue by Countries
8.1 South America Cell Viability Assays Revenue by Countries (2015-2020)
8.2 Brazil Cell Viability Assays Revenue and Growth Rate (2015-2020)
8.3 Argentina Cell Viability Assays Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Cell Viability Assays by Countries
9.1 Middle East & Africa Cell Viability Assays Revenue by Countries (2015-2020)
9.2 Saudi Arabia Cell Viability Assays Revenue and Growth Rate (2015-2020)
9.3 UAE Cell Viability Assays Revenue and Growth Rate (2015-2020)
9.4 Egypt Cell Viability Assays Revenue and Growth Rate (2015-2020)
9.5 South Africa Cell Viability Assays Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Cell Viability Assays Revenue and Market Share by Type (2015-2020)
10.2 Global Cell Viability Assays Market Forecast by Type (2019-2024)
10.3 Human Cells Revenue Growth Rate (2015-2025)
10.4 Microbial Cells Revenue Growth Rate (2015-2025)
10.5 Animal Cells Revenue Growth Rate (2015-2025)
11 Global Cell Viability Assays Market Segment by Application
11.1 Global Cell Viability Assays Revenue Market Share by Application (2015-2020)
11.2 Cell Viability Assays Market Forecast by Application (2019-2024)
11.3 Pharmaceutical and Biotechnology Companies Revenue Growth (2015-2020)
11.4 Academic and Research Institutes Revenue Growth (2015-2020)
11.5 Hospital and Diagnostic Laboratories Revenue Growth (2015-2020)
11.6 Others Revenue Growth (2015-2020)
12 Global Cell Viability Assays Market Size Forecast (2021-2025)
12.1 Global Cell Viability Assays Market Size Forecast (2021-2025)
12.2 Global Cell Viability Assays Market Forecast by Regions (2021-2025)
12.3 North America Cell Viability Assays Revenue Market Forecast (2021-2025)
12.4 Europe Cell Viability Assays Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Cell Viability Assays Revenue Market Forecast (2021-2025)
12.6 South America Cell Viability Assays Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Cell Viability Assays Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Cell Viability Assays Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Cell Viability Assays by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Cell Viability Assays Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Cell Viability Assays Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Thermo Fisher Scientific Corporate Information, Location and Competitors
Table 6. Thermo Fisher Scientific Cell Viability Assays Major Business
Table 7. Thermo Fisher Scientific Cell Viability Assays Total Revenue (USD Million) (2017-2018)
Table 8. Thermo Fisher Scientific SWOT Analysis
Table 9. Thermo Fisher Scientific Cell Viability Assays Product and Solutions
Table 10. Thermo Fisher Scientific Cell Viability Assays Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Promega Corporate Information, Location and Competitors
Table 12. Promega Cell Viability Assays Major Business
Table 13. Promega Cell Viability Assays Total Revenue (USD Million) (2018-2019)
Table 14. Promega SWOT Analysis
Table 15. Promega Cell Viability Assays Product and Solutions
Table 16. Promega Cell Viability Assays Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. GE Corporate Information, Location and Competitors
Table 18. GE Cell Viability Assays Major Business
Table 19. GE Cell Viability Assays Total Revenue (USD Million) (2017-2018)
Table 20. GE SWOT Analysis
Table 21. GE Cell Viability Assays Product and Solutions
Table 22. GE Cell Viability Assays Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Merck Corporate Information, Location and Competitors
Table 24. Merck Cell Viability Assays Major Business
Table 25. Merck Cell Viability Assays Total Revenue (USD Million) (2017-2018)
Table 26. Merck SWOT Analysis
Table 27. Merck Cell Viability Assays Product and Solutions
Table 28. Merck Cell Viability Assays Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. PerkinElmer Corporate Information, Location and Competitors
Table 30. PerkinElmer Cell Viability Assays Major Business
Table 31. PerkinElmer Cell Viability Assays Total Revenue (USD Million) (2017-2018)
Table 32. PerkinElmer SWOT Analysis
Table 33. PerkinElmer Cell Viability Assays Product and Solutions
Table 34. PerkinElmer Cell Viability Assays Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Bio-Rad Corporate Information, Location and Competitors
Table 36. Bio-Rad Cell Viability Assays Major Business
Table 37. Bio-Rad Cell Viability Assays Total Revenue (USD Million) (2017-2018)
Table 38. Bio-Rad SWOT Analysis
Table 39. Bio-Rad Cell Viability Assays Product and Solutions
Table 40. Bio-Rad Cell Viability Assays Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Abcam Corporate Information, Location and Competitors
Table 42. Abcam Cell Viability Assays Major Business
Table 43. Abcam Cell Viability Assays Total Revenue (USD Million) (2017-2018)
Table 44. Abcam SWOT Analysis
Table 45. Abcam Cell Viability Assays Product and Solutions
Table 46. Abcam Cell Viability Assays Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. BD Corporate Information, Location and Competitors
Table 48. BD Cell Viability Assays Major Business
Table 49. BD Cell Viability Assays Total Revenue (USD Million) (2017-2018)
Table 50. BD SWOT Analysis
Table 51. BD Cell Viability Assays Product and Solutions
Table 52. BD Cell Viability Assays Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Danaher Corporate Information, Location and Competitors
Table 54. Danaher Cell Viability Assays Major Business
Table 55. Danaher Cell Viability Assays Total Revenue (USD Million) (2017-2018)
Table 56. Danaher SWOT Analysis
Table 57. Danaher Cell Viability Assays Product and Solutions
Table 58. Danaher Cell Viability Assays Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Biotium Corporate Information, Location and Competitors
Table 60. Biotium Cell Viability Assays Major Business
Table 61. Biotium Cell Viability Assays Total Revenue (USD Million) (2017-2018)
Table 62. Biotium SWOT Analysis
Table 63. Biotium Cell Viability Assays Product and Solutions
Table 64. Biotium Cell Viability Assays Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Creative Bioarray Corporate Information, Location and Competitors
Table 66. Creative Bioarray Cell Viability Assays Major Business
Table 67. Creative Bioarray Cell Viability Assays Total Revenue (USD Million) (2017-2018)
Table 68. Creative Bioarray SWOT Analysis
Table 69. Creative Bioarray Cell Viability Assays Product and Solutions
Table 70. Creative Bioarray Cell Viability Assays Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Biotek Instruments Corporate Information, Location and Competitors
Table 72. Biotek Instruments Cell Viability Assays Major Business
Table 73. Biotek Instruments Cell Viability Assays Total Revenue (USD Million) (2017-2018)
Table 74. Biotek Instruments SWOT Analysis
Table 75. Biotek Instruments Cell Viability Assays Product and Solutions
Table 76. Biotek Instruments Cell Viability Assays Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Global Cell Viability Assays Revenue (Million USD) by Players (2015-2020)
Table 78. Global Cell Viability Assays Revenue Share by Players (2015-2020)
Table 79. Global Cell Viability Assays Revenue (Million USD) by Regions (2015-2020)
Table 80. Global Cell Viability Assays Revenue Market Share by Regions (2015-2020)
Table 81. North America Cell Viability Assays Revenue by Countries (2015-2020)
Table 82. North America Cell Viability Assays Revenue Market Share by Countries (2015-2020)
Table 83. Europe Cell Viability Assays Revenue (Million USD) by Countries (2015-2020)
Table 84. Asia-Pacific Cell Viability Assays Revenue (Million USD) by Countries (2015-2020)
Table 85. South America Cell Viability Assays Revenue by Countries (2015-2020)
Table 86. South America Cell Viability Assays Revenue Market Share by Countries (2015-2020)
Table 87. Middle East and Africa Cell Viability Assays Revenue (Million USD) by Countries (2015-2020)
Table 88. Middle East and Africa Cell Viability Assays Revenue Market Share by Countries (2015-2020)
Table 89. Global Cell Viability Assays Revenue (Million USD) by Type (2015-2020)
Table 90. Global Cell Viability Assays Revenue Share by Type (2015-2020)
Table 91. Global Cell Viability Assays Revenue Forecast by Type (2021-2025)
Table 92. Global Cell Viability Assays Revenue by Application (2015-2020)
Table 93. Global Cell Viability Assays Revenue Share by Application (2015-2020)
Table 94. Global Cell Viability Assays Revenue Forecast by Application (2021-2025)
Table 95. Global Cell Viability Assays Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Cell Viability Assays Picture
Figure 2. Global Cell Viability Assays Revenue Market Share by Type in 2019
Figure 3. Human Cells Picture
Figure 4. Microbial Cells Picture
Figure 5. Animal Cells Picture
Figure 6. Cell Viability Assays Revenue Market Share by Application in 2019
Figure 7. Pharmaceutical and Biotechnology Companies Picture
Figure 8. Academic and Research Institutes Picture
Figure 9. Hospital and Diagnostic Laboratories Picture
Figure 10. Others Picture
Figure 11. Global Cell Viability Assays Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America Cell Viability Assays Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe Cell Viability Assays Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific Cell Viability Assays Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America Cell Viability Assays Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa Cell Viability Assays Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Cell Viability Assays Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Cell Viability Assays Revenue Share by Players in 2019
Figure 19. Global Top 5 Players Cell Viability Assays Revenue Market Share in 2019
Figure 20. Global Top 10 Players Cell Viability Assays Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global Cell Viability Assays Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global Cell Viability Assays Revenue Market Share by Regions (2015-2020)
Figure 24. Global Cell Viability Assays Revenue Market Share by Regions in 2018
Figure 25. North America Cell Viability Assays Revenue and Growth Rate (2015-2020)
Figure 26. Europe Cell Viability Assays Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific Cell Viability Assays Revenue and Growth Rate (2015-2020)
Figure 28. South America Cell Viability Assays Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa Cell Viability Assays Revenue and Growth Rate (2015-2020)
Figure 30. North America Cell Viability Assays Revenue Market Share by Countries (2015-2020)
Figure 31. North America Cell Viability Assays Revenue Market Share by Countries in 2019
Figure 32. USA Cell Viability Assays Revenue and Growth Rate (2015-2020)
Figure 33. Canada Cell Viability Assays Revenue and Growth Rate (2015-2020)
Figure 34. Mexico Cell Viability Assays Revenue and Growth Rate (2015-2020)
Figure 35. Europe Cell Viability Assays Revenue Market Share by Countries (2015-2020)
Figure 36. Europe Cell Viability Assays Revenue Market Share by Countries in 2019
Figure 37. Germany Cell Viability Assays Revenue and Growth Rate (2015-2020)
Figure 38. UK Cell Viability Assays Revenue and Growth Rate (2015-2020)
Figure 39. France Cell Viability Assays Revenue and Growth Rate (2015-2020)
Figure 40. Russia Cell Viability Assays Revenue and Growth Rate (2015-2020)
Figure 41. Italy Cell Viability Assays Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Cell Viability Assays Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific Cell Viability Assays Revenue Market Share by Countries in 2019
Figure 44. China Cell Viability Assays Revenue and Growth Rate (2015-2020)
Figure 45. Japan Cell Viability Assays Revenue and Growth Rate (2015-2020)
Figure 46. Korea Cell Viability Assays Revenue and Growth Rate (2015-2020)
Figure 47. India Cell Viability Assays Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia Cell Viability Assays Revenue and Growth Rate (2015-2020)
Figure 49. South America Cell Viability Assays Revenue Market Share by Countries (2015-2020)
Figure 50. South America Cell Viability Assays Revenue Market Share by Countries in 2019
Figure 51. Brazil Cell Viability Assays Revenue and Growth Rate (2015-2020)
Figure 52. Argentina Cell Viability Assays Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa Cell Viability Assays Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa Cell Viability Assays Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia Cell Viability Assays Revenue and Growth Rate (2015-2020)
Figure 56. UAE Cell Viability Assays Revenue and Growth Rate (2015-2020)
Figure 57. Egypt Cell Viability Assays Revenue and Growth Rate (2015-2020)
Figure 58. South Africa Cell Viability Assays Revenue and Growth Rate (2015-2020)
Figure 59. Global Cell Viability Assays Revenue Share by Type (2015-2020)
Figure 60. Global Cell Viability Assays Revenue Share by Type in 2019
Figure 61. Global Cell Viability Assays Market Share Forecast by Type (2021-2025)
Figure 62. Global Human Cells Revenue Growth Rate (2015-2020)
Figure 63. Global Microbial Cells Revenue Growth Rate (2015-2020)
Figure 64. Global Animal Cells Revenue Growth Rate (2015-2020)
Figure 65. Global Cell Viability Assays Revenue Share by Application (2015-2020)
Figure 66. Global Cell Viability Assays Revenue Share by Application in 2019
Figure 67. Global Cell Viability Assays Market Share Forecast by Application (2021-2025)
Figure 68. Global Pharmaceutical and Biotechnology Companies Revenue Growth Rate (2015-2020)
Figure 69. Global Academic and Research Institutes Revenue Growth Rate (2015-2020)
Figure 70. Global Hospital and Diagnostic Laboratories Revenue Growth Rate (2015-2020)
Figure 71. Global Others Revenue Growth Rate (2015-2020)
Figure 72. Global Cell Viability Assays Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global Cell Viability Assays Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global Cell Viability Assays Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America Cell Viability Assays Revenue Market Forecast (2021-2025)
Figure 76. Europe Cell Viability Assays Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific Cell Viability Assays Revenue Market Forecast (2021-2025)
Figure 78. South America Cell Viability Assays Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa Cell Viability Assays Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
カスタムアッセイの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Custom Assays market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.7% in the forecast period of 2020 to 2025 and will expected to reach USD 45310 million by 2025, from USD 37750 million in 2019. The Custom Assays market rep…- バイオハイブリッド太陽電池の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Biohybrid Solar Cell market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, …
- 自動車用水素燃料電池の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Automotive Hydrogen Fuel Cell market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optim…
- 自動車用プロトン交換膜燃料電池の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Automotive Proton Exchange Membrane Fuel Cell market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, v…
- 胎盤幹細胞収集・保管の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Placental Stem Cell Collection and Storage market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, valu…